All Square Wealth Management LLC Crispr Therapeutics Ag Transaction History
All Square Wealth Management LLC
- $172 Million
- Q4 2024
A detailed history of All Square Wealth Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, All Square Wealth Management LLC holds 253 shares of CRSP stock, worth $9,568. This represents 0.01% of its overall portfolio holdings.
Number of Shares
253
Previous 309
18.12%
Holding current value
$9,568
Previous $14,000
35.71%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding CRSP
# of Institutions
482Shares Held
64.2MCall Options Held
1.64MPut Options Held
1.93M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$339 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$331 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$144 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$105 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$104 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.95B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....